BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 26224425)

  • 1. Glycemic control in the critically ill: What have we learned since NICE-SUGAR?
    Krinsley JS
    Hosp Pract (1995); 2015; 43(3):191-7. PubMed ID: 26224425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of published scientific evidence on glycemic control in adult intensive care units.
    Niven DJ; Rubenfeld GD; Kramer AA; Stelfox HT
    JAMA Intern Med; 2015 May; 175(5):801-9. PubMed ID: 25775163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding glycemic control in the critically ill: 2011 update.
    Krinsley JS
    Hosp Pract (1995); 2011 Apr; 39(2):47-55. PubMed ID: 21576897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients.
    Krinsley JS; Meyfroidt G; van den Berghe G; Egi M; Bellomo R
    Curr Opin Clin Nutr Metab Care; 2012 Mar; 15(2):151-60. PubMed ID: 22234163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glycaemia control in critically ill patients is justified and effective].
    Rybka J
    Vnitr Lek; 2010 Sep; 56(9 Suppl):977-87. PubMed ID: 21137171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intensive or conventional glucose control in critically ill patients: NICE-SUGAR (The Normoglycemia in Intensive Care Evaluation-Survival Using Glucose Algorithm Regulation Study)].
    Jacob S; Nitschmann S
    Internist (Berl); 2010 May; 51(5):670, 672-3. PubMed ID: 20352176
    [No Abstract]   [Full Text] [Related]  

  • 8. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
    Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
    Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive insulin therapy for critically ill patients.
    Lewis KS; Kane-Gill SL; Bobek MB; Dasta JF
    Ann Pharmacother; 2004; 38(7-8):1243-51. PubMed ID: 15187219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glucose variability in intensive care unit].
    Schaal JV; Libert N; De Rudnicki S; Auroy Y; Mérat S
    Ann Fr Anesth Reanim; 2012 Dec; 31(12):950-60. PubMed ID: 23107472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus recommendations for the management of hyperglycaemia in critically ill patients in the Indian setting.
    Mukherjee JJ; Chatterjee PS; Saikia M; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):16-25. PubMed ID: 25668933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should guidelines for glycemic control of the critically ill be individualized?: Weighing the evidence from randomized and observational investigations.
    Krinsley JS
    Hosp Pract (1995); 2014 Apr; 42(2):14-22. PubMed ID: 24769780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in practice of blood glucose control in critically ill patients in the Netherlands.
    van Hooijdonk RT; Eslami S; de Keizer NF; Bakhshi-Raiez F; Bosman RJ; Dongelmans DA; van der Voort PH; Streefkerk JO; Engelbrecht WJ; ten Cate J; Huissoon S; van Driel EM; van Dijk I; Cimic N; Beck OF; Snellen FT; Holman ND; Mulder HC; Abu-Hanna A; Schultz MJ
    Neth J Med; 2015 Dec; 73(10):455-63. PubMed ID: 26687261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients.
    Pinelli NR; Jones MC; Monday LM; Smith Z; Rhoney DH
    Ann Pharmacother; 2012 Jan; 46(1):124-9. PubMed ID: 22202493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Don't Sugar Coat It: Glycemic Control in the Intensive Care Unit.
    Stoudt K; Chawla S
    J Intensive Care Med; 2019; 34(11-12):889-896. PubMed ID: 30309291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood glucose concentration and outcome of critical illness: the impact of diabetes.
    Egi M; Bellomo R; Stachowski E; French CJ; Hart GK; Hegarty C; Bailey M
    Crit Care Med; 2008 Aug; 36(8):2249-55. PubMed ID: 18664780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic control in the critically ill patient an update: hyperglycemia, glucose variability hypoglycemia and relative hypoglycemia].
    Pérez-Calatayud ÁA; Guillén-Vidaña A; Fraire-Félix IS; Anica-Malagón ED; Briones Garduño JC; Carrillo-Esper R
    Cir Cir; 2017; 85(1):93-100. PubMed ID: 27998542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.
    Klonoff DC
    J Diabetes Sci Technol; 2011 May; 5(3):755-67. PubMed ID: 21722591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions.
    Braithwaite SS; Edkins R; Macgregor KL; Sredzienski ES; Houston M; Zarzaur B; Rich PB; Benedetto B; Rutherford EJ
    Diabetes Technol Ther; 2006 Aug; 8(4):476-88. PubMed ID: 16939372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Space Glucose Control and Routine Glucose Management Protocol for Glycemic Control in Critically Ill Patients: A Prospective, Randomized Clinical Study.
    Xu B; Jiang W; Wang CY; Weng L; Hu XY; Peng JM; Du B
    Chin Med J (Engl); 2017 Sep; 130(17):2041-2049. PubMed ID: 28836546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.